Briakinumab [339308-60-0]

TargetMol Chemicals

Briakinumab

9

339308-60-0

Antibody

Research Use Only

Briakinumab

Briakinumab (ABT-874), a fully human anti-IL-12/23p40 monoclonal antibody, selectively targets and neutralizes IL-12 and IL-23. This compound is utilized in the research of various autoimmune disorders, including rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis [1].

3 years

-20°C

12352203